T1	Condition 19 41	pulmonary hypertension
T3	Condition 175 205	chronic disease involved liver
T4	Temporal 166 171	acute
T5	Qualifier 158 165	serious
T6	Condition 175 199;207 213	chronic disease involved kidney
T7	Condition 175 199;219 224	chronic disease involved brain
*	OR T6 T7 T3
T8	Scope 175 224	chronic disease involved liver, kidney, and brain
R1	Has_temporal Arg1:T8 Arg2:T4	
R2	Has_qualifier Arg1:T8 Arg2:T5	
T9	Drug 247 263	CYP3A4-inhibitor
T10	Drug 267 274	nitrate
T11	Qualifier 240 246	potent
T12	Drug 350 360	sildenafil
T13	Condition 365 368	PAH
T14	Drug 379 389	sildenafil
T15	Drug 393 402	tadalafil
*	OR T14 T15 T12
T16	Observation 411 446	contraindications in package insert
T2	Observation 57 102	refuse to subscribe written informed consents
T17	Observation 106 136	can't cooperate with the trial
*	OR T2 T17
T18	Condition 288 307	underlying diseases
T19	Scope 247 274	CYP3A4-inhibitor or nitrate
*	OR T9 T10
R3	Has_qualifier Arg1:T19 Arg2:T11	
R4	AND Arg1:T19 Arg2:T18	
T20	Qualifier 4 15	other types
R6	Has_qualifier Arg1:T1 Arg2:T20	
T21	Temporal 327 336	currently
T22	Scope 350 402	sildenafil for PAH or taking sildenafil or tadalafil
R7	Has_temporal Arg1:T22 Arg2:T21	
